REQUEST A DEMO
Total
USD $0.00
Search more companies

Svk Pharma Private Limited (India)

Main Activities: Basic Chemical Manufacturing
Full name: Svk Pharma Private Limited Profile Updated: December 20, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Svk Pharma Private Limited is an unlisted company, incorporated on 13/01/2011. It has its registered office in the State of Telangana, India. Company's corporate identification number (CIN) is U24100TG2011PTC072241 and registration number is 072241. The company is a manufacturing, trade company, it is engaged in chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products, wholesale trading.

Legal Address
Plot No.205/2A, 1St Floor, Phase-Ii, Ida, Cherlapally, Kapra Mandal, Medchal,Malkajgiri Dist
Rangareddy; Andhra Pradesh; Postal Code: 500051

Contact Details: Purchase the Svk Pharma Private Limited report to view the information.

Basic Information
Total Employees:
Purchase the Svk Pharma Private Limited report to view the information.
Outstanding Shares:
Purchase the Svk Pharma Private Limited report to view the information.
Registered Capital:
Purchase the Svk Pharma Private Limited report to view the information.
Incorporation Date:
January 13, 2011
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Company Performance
Financial values in the chart are available after Svk Pharma Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
4.82%
Total operating revenue
4.44%
Operating profit (EBIT)
15.91%
EBITDA
4.11%
Net Profit (Loss) for the Period
15.91%
Total assets
9.55%
Total equity
14.55%
Operating Profit Margin (ROS)
0.27%
Net Profit Margin
0.2%
Return on Equity (ROE)
0.15%
Debt to Equity Ratio
-21.02%
Quick Ratio
0%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?